We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Back to rankings

58 hedge funds and large institutions have $339M invested in Prevail Therapeutics Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

26% more funds holding

Funds holding: 46 → 58 (+12)

21% less capital invested

Capital invested by funds: $427M → $339M (-$87.9M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
58
Holders Change
+12
Holders Change %
+26.09%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
25
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.72M
2
CI
Clal Insurance
Israel
+$4.57M
3
WP
Woodline Partners
California
+$4M
4
AG
Artal Group
Luxembourg
+$3.18M
5
QF
QVT Financial
New York
+$2.13M

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$6.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.14M
3
BI
BVF Inc
California
-$3.58M
4
RCM
RA Capital Management
Massachusetts
-$1.96M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
AS
26
Altshuler Shaham
Israel
$633K +$23.4K +1,473 +3%
N
27
Nuveen
North Carolina
$606K +$507K +31,899 +179%
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$528K -$5.14M -322,977 -88%
JP Morgan Chase
29
JP Morgan Chase
New York
$389K +$284K +17,856 +126%
Charles Schwab
30
Charles Schwab
California
$363K +$224K +14,054 +90%
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$265K +$165K +10,400 +92%
Wells Fargo
32
Wells Fargo
California
$260K +$147K +9,225 +76%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$260K +$155K +9,769 +85%
Goldman Sachs
34
Goldman Sachs
New York
$252K +$80.9K +5,086 +33%
Two Sigma Investments
35
Two Sigma Investments
New York
$248K +$323K +20,311 New
Squarepoint
36
Squarepoint
New York
$209K -$47.3K -2,972 -15%
DTL
37
Dynamic Technology Lab
Singapore
$159K +$208K +13,054 New
Los Angeles Capital Management
38
Los Angeles Capital Management
California
$159K +$208K +13,080 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$147K +$193K +12,100 New
Barclays
40
Barclays
United Kingdom
$121K +$37.4K +2,352 +31%
Victory Capital Management
41
Victory Capital Management
Texas
$116K +$151K +9,496 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$111K – – –
AIG
43
American International Group
New York
$101K +$58.3K +3,662 +79%
MIM
44
MetLife Investment Management
New Jersey
$87.1K +$114K +7,148 New
Citigroup
45
Citigroup
New York
$81K +$40.5K +2,546 +62%
CSS
46
Cubist Systematic Strategies
Connecticut
$65K +$61.2K +3,847 +261%
MLICM
47
Metropolitan Life Insurance Company (MetLife)
New York
$61.6K +$80.4K +5,055 New
Deutsche Bank
48
Deutsche Bank
Germany
$61K +$39.3K +2,468 +96%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$50.5K +$52.2K +3,279 +380%
Legal & General Group
50
Legal & General Group
United Kingdom
$26K +$11.4K +716 +50%
1
2
3

PRVL Hedge Fund Activity: Q1 2020 in Review

58 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Prevail Therapeutics Inc. Common Stock (PRVL) for Q1 2020, worth a combined $339M — down 21% from $427M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PRVL positions and 2 closed out — a net gain of 12 holders — while 25 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $6.72M. The largest seller was Omega Fund Management, cutting an estimated $6.3M.

  • 58 institutional investors held Prevail Therapeutics Inc. Common Stock (PRVL) as of Q1 2020, up from 46 in Q4 2019.
  • Funds reported $339M of Prevail Therapeutics Inc. Common Stock stock for Q1 2020, down 21% quarter-over-quarter.
  • 14 funds opened new Prevail Therapeutics Inc. Common Stock positions in Q1 2020 and 2 closed out, a net change of +12 holders.
  • The largest Prevail Therapeutics Inc. Common Stock buyer in Q1 2020 was BlackRock, an estimated $6.72M added.
  • The largest Prevail Therapeutics Inc. Common Stock seller in Q1 2020 was Omega Fund Management, an estimated $6.3M sold.

Based on aggregated 13F filings for Q1 2020.